GenomOncology and WeTrials Forge Alliance to Enhance Clinical Trial Enrollment for CNS Cancer Patients GenomOncology partners with WeTrials to streamline clinical trial enrollment for CNS cancer patients, enhancing access to potential therapies.

GenomOncology and WeTrials Forge Alliance to Enhance Clinical Trial Enrollment for CNS Cancer Patients #United_States #Cleveland #GenomOncology #CNS_Cancer #WeTrials